FDA Inspection 1160493 — Median Technologies
The FDA completed an inspection of Median Technologies on November 12, 2021 in Valbonne. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 12, 2021
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Valbonne (France)
Additional Details
Sponsor, Contract Research Organization